Methyl 3-chloro-1H-pyrazole-4-carboxylate

Catalog No.: 
ACNZYD862
CAS No.: 
2089301-64-2
Molecular Formula: 
C5H5ClN2O2
Molecular Weight: 
160.56
Methyl 3-chloro-1H-pyrazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$58.00In stockInquiry
250mg97%$98.00In stockInquiry
1g97%$249.00In stockInquiry
5g97%$677.00In stockInquiry
10g97%$1103.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-chloro-1H-pyrazole-4-carboxylate
IUPAC Namemethyl 3-chloro-1H-pyrazole-4-carboxylate
MDL No.MFCD29761003
Molecular FormulaC5H5ClN2O2
Molecular Weight160.56
SMILESO=C(C1=CNN=C1Cl)OC
InChI KeyJRXOEEUOYWFKHF-UHFFFAOYSA-N
SynonymMethyl 3-chloro-1H-pyrazole-4-carboxylate;1H-Pyrazole-4-carboxylic acid, 3-chloro-, methyl ester;methyl 5-chloro-1H-pyrazole-4-carboxylate
CAS No.2089301-64-2
PubChem CID92135045

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNZYD862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACEOPF018 route compound structure diagram
    ACEOPF0181186049-67-1In Stock
  4. Then
  5. ACNZYD862 route product structure diagram
    ACNZYD8622089301-64-2In Stock
Inquiry

2. ACNZYD862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZYD862 route product structure diagram
    ACNZYD8622089301-64-2In Stock
Inquiry

3. ACNZYD862 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZYD862 route product structure diagram
    ACNZYD8622089301-64-2In Stock
Inquiry

Comments (0)